Alzheimer’s disease-linked PS1 mutants in the beta-catenin-signaling pathway. J Neurosci 19: 4229–4237. 25. Soriano S, Kang DE, Fu M, Pestell R, Chevallier N, et al. (2001) Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol 152: 785–794. 26. Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-3alpha regulates production of Alzheimer’s disease amyloid-beta peptides. Nature 423: 435–439. 27. Toledo EM, Inestrosa NC (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer’s disease. Mol Psychiatry 15: 272–285, 228. 28. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen synthase kinase-3 induces Alzheimer’s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147: 58–62. 29. De Ferrari GV, Papassotiropoulos A, Biechele T, Wavrant De-Vrieze F, Avila ME, et al. (2007) Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer’s disease. Proc Natl Acad Sci U S A 104: 9434–9439. 30. De Ferrari GV, Chacon MA, Barria MI, Garrido JL, Godoy JA, et al. (2003) Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry 8: 195–208. 31. Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, et al. (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer’s brain. J Neurosci 24: 6021–6027. 32. Rosi MC, Luccarini I, Grossi C, Fiorentini A, Spillantini MG, et al. (2010) Increased Dickkopf-1 expression in transgenic mouse models of neurodegener- ative disease. Journal of Neurochemistry 112: 1539–1551. 33. Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, et al. (2008) Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem 283: 9359–9368. 34. Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, et al. (2004) Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297: 186–196. 35. Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M (2005) Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling. Exp Cell Res 304: 91–104. 36. Cerpa W, Farias GG, Godoy JA, Fuenzalida M, Bonansco C, et al. (2010) Wnt- 5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Mol Neurodegener 5: 3. 37. Dahlgren KN, Manelli AM, Stine WB, Jr., Baker LK, Krafft GA, et al. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277: 32046–32053. 38. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97–100. 39. Gong R, Park CS, Abbassi NR, Tang SJ (2006) Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity- dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem 281: 18802–18815. 40. Tang SJ, Reis G, Kang H, Gingras AC, Sonenberg N, et al. (2002) A rapamycin- sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci U S A 99: 467–472. 41. Ma F, Wang H, Chen B, Wang F, Xu H (2011) Metallothionein 3 attenuated the apoptosis of neurons in the CA1 region of the hippocampus in the senescence- accelerated mouse/PRONE8 (SAMP8). Arq Neuropsiquiatr 69: 105–111. 42. Chen J, Park CS, Tang SJ (2006) Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem 281: 11910–11916. 43. Crawley JN, Gerfen CR, Rogawski MA, Sibley DR, Skolnick P, et al. (2007) Short Protocols in Neuroscience: Systems and Behavioral Methods. Hoboken: Wiley. pp 2–30. 44. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, et al. (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891: 42–53. 45. Kuhl M, Sheldahl LC, Malbon CC, Moon RT (2000) Ca(2+)/calmodulin- dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem 275: 12701–12711. Wnt5a in AD 46. Parodi J, Sepulveda FJ, Roa J, Opazo C, Inestrosa NC, et al. (2010) Beta- amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285: 2506–2514. 47. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101–112. 48. Klein WL, Krafft GA, Finch CE (2001) Targeting small Abeta oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 24: 219–224. 49. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817–827. 50. Qin L, Liu Y, Cooper C, Liu B, Wilson B, et al. (2002) Microglia enhance beta- amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83: 973–983. 51. Tabner BJ, El-Agnaf OM, Turnbull S, German MJ, Paleologou KE, et al. (2005) Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J Biol Chem 280: 35789–35792. 52. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, et al. (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A 92: 1989–1993. 53. Jenei V, Sherwood V, Howlin J, Linnskog R, Safholm A, et al. (2009) A t- butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci U S A 106: 19473–19478. 54. He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, et al. (1997) A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 275: 1652–1654. 55. Safholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutreix BO, et al. (2006) A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. J Biol Chem 281: 2740–2749. 56. Pereira C, Schaer DJ, Bachli EB, Kurrer MO, Schoedon G (2008) Wnt5A/ CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 28: 504–510. 57. Kim J, Kim J, Kim DW, Ha Y, Ihm MH, et al. (2010) Wnt5a induces endothelial inflammation via beta-catenin-independent signaling. J Immunology 185: 1274–1282. 58. Sen M, Ghosh S (2008) Transcriptional outcome of Wnt-Frizzled signal transduction in inflammation: evolving concepts. J Immunology 181: 4441–4445. 59. Xiao G, Harhaj EW, Sun SC (2001) NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7: 401–409. 60. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225–260. 61. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, et al. (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24: 516–524. 62. Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, et al. (2002) Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer’s disease. Bipolar Disord 4: 153–165. 63. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, et al. (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta- catenin degradation. J Cell Biol 162: 899–908. 64. Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, et al. (2000) Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A 97: 2791–2796. 65. Christman MA, 2nd, Goetz DJ, Dickerson E, McCall KD, Lewis CJ, et al. (2008) Wnt5a is expressed in murine and human atherosclerotic lesions. Am J Physiol Heart Circ Physiol 294: H2864–2870. 66. Camilli TC, Weeraratna AT (2010) Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression. Biochem Pharmacol 80: 702–711. 67. Suarez-Farinas M, Fuentes-Duculan J, Lowes MA, Krueger JG (2011) Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 131: 391–400. 68. Halleskog C, Mulder J, Dahlstro¨m J, Mackie K, Hortoba´gyi T, et al. (2011) WNT signaling in activated microglia is proinflammatory. Glia 59: 119–131. PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e22920